PMID- 25132678 OWN - NLM STAT- MEDLINE DCOM- 20150611 LR - 20220330 IS - 2042-6984 (Electronic) IS - 2042-6976 (Linking) VI - 4 IP - 10 DP - 2014 Oct TI - Chronic rhinosinusitis patients have decreased lung function. PG - 828-33 LID - 10.1002/alr.21370 [doi] AB - BACKGROUND: The relationship between upper and lower airway diseases has been reported. However, the pulmonary function of patients with chronic rhinosinusitis (CRS) has not been fully examined. METHODS: Pulmonary function was measured in 273 patients with CRS and 100 age-matched normal control subjects. No patients with chronic obstructive pulmonary disease (COPD) were included in this study. The patients with CRS were divided into 8 subgroups based on the presence of asthma, sensitization to common inhaled antigens, and nasal polyposis. The relationships between pulmonary function and clinical parameters, including radiographic severity of CRS according to the Lund-Mackay computed tomography (CT) staging system, eosinophil count in the peripheral blood, and serum total immunoglobulin E (IgE) levels, were assessed. RESULTS: In pulmonary function testing, the CRS patients had affected pulmonary function. The CRS patients without asthma showed latent obstructive pulmonary function changes when compared to normal controls. No significant correlations were observed between pulmonary function and any clinical parameters (Lund-Mackay CT staging score, eosinophil count in the peripheral blood, and serum total IgE levels). CONCLUSION: CRS patients had significant obstructive lung function changes regardless of the presence of asthma. The patients with CRS who had not been clinically diagnosed as having lower respiratory tract diseases might have had subclinical lower airway diseases. Therefore, clinicians should be aware of pulmonary function and lower lung diseases in patients with CRS. CI - (c) 2014 ARS-AAOA, LLC. FAU - Kariya, Shin AU - Kariya S AD - Department of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. FAU - Okano, Mitsuhiro AU - Okano M FAU - Higaki, Takaya AU - Higaki T FAU - Noyama, Yasuyuki AU - Noyama Y FAU - Haruna, Takenori AU - Haruna T FAU - Ishihara, Hisashi AU - Ishihara H FAU - Makino, Takuma AU - Makino T FAU - Onoda, Tomoo AU - Onoda T FAU - Nishizaki, Kazunori AU - Nishizaki K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140813 PL - United States TA - Int Forum Allergy Rhinol JT - International forum of allergy & rhinology JID - 101550261 RN - 37341-29-0 (Immunoglobulin E) SB - IM CIN - Allergol Int. 2020 Jan;69(1):144-145. PMID: 31495652 MH - Adult MH - Aged MH - Airway Obstruction/physiopathology MH - Chronic Disease MH - Female MH - Humans MH - Immunoglobulin E/blood MH - Leukocyte Count MH - Lung/*physiopathology MH - Male MH - Middle Aged MH - Respiratory Function Tests MH - Rhinitis/*physiopathology MH - Severity of Illness Index MH - Sinusitis/*physiopathology MH - Tomography, X-Ray Computed OTO - NOTNLM OT - asthma OT - chronic obstructive pulmonary disease OT - pulmonary function OT - rhinitis OT - sinusitis EDAT- 2014/08/19 06:00 MHDA- 2015/06/13 06:00 CRDT- 2014/08/19 06:00 PHST- 2014/04/12 00:00 [received] PHST- 2014/06/07 00:00 [revised] PHST- 2014/06/10 00:00 [accepted] PHST- 2014/08/19 06:00 [entrez] PHST- 2014/08/19 06:00 [pubmed] PHST- 2015/06/13 06:00 [medline] AID - 10.1002/alr.21370 [doi] PST - ppublish SO - Int Forum Allergy Rhinol. 2014 Oct;4(10):828-33. doi: 10.1002/alr.21370. Epub 2014 Aug 13.